英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
nant查看　nant　在百度字典中的解释百度英翻中〔查看〕
nant查看　nant　在Google字典中的解释Google英翻中〔查看〕
nant查看　nant　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • FRUZAQLA® (fruquintinib) for Previously Treated mCRC
    What is FRUZAQLA® (fruquintinib)? For adults with metastatic colorectal cancer (mCRC), FRUZAQLA is an innovative and convenient oral treatment with proven survival results that can be taken after chemotherapy and other anti-cancer medications FRUZAQLA is a targeted therapy for people living with previously treated mCRC FRUZAQLA is not
  • Metastatic Colorectal Cancer (mCRC) Patient Resources
    What is FRUZAQLA® (fruquintinib)? FRUZAQLA is a prescription medicine used to treat adults with colon or rectal cancer that has spread to other parts of the body (metastatic colorectal cancer [mCRC]) and who have received previous treatment with certain anti-cancer medicines
  • Access Guide - FRUZAQLA® (fruquintinib)
    FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‐, oxaliplatin‐, and irinotecan‐based chemotherapy, an anti‐VEGF therapy, and, if RAS wild‐type and medically appropriate, an anti‐EGFR therapy
  • FRUZAQLA® (fruquintinib) for Previously Treated mCRC
    FRUZAQLA® is a once-daily non-chemotherapy treatment for adults with previously treated metastatic colorectal cancer (mCRC) See Important Safety and Prescribing information
  • label - accessdata. fda. gov
    FRUZAQLA is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy
  • Fruzaqla (Fruquintinib): Uses, Side Effects, Interactions . . .
    Find patient medical information for Fruzaqla (Fruquintinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
  • Fruzaqla: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Fruzaqla is an oral kinase inhibitor that may be used to treat adults with metastatic colorectal cancer (mCRC), regardless of biomarker status, who have been previously treated with specific chemotherapy agents or targeted treatments
  • This label may not be the latest approved by FDA. For current . . .
    FRUZAQLA (fruquintinib) capsules for oral administration contain 1mg or 5 mg of fruquintinib The inactive ingredients are corn starch, microcrystalline cellulose, and talc
  • Fruquintinib (Fruzaqla ) for the management of colorectal cancer
    Fruquintinib (Fruzaqla®) for the management of colorectal cancer Description: The purpose of this PQI is to review clinical information regarding fruquintinib (Fruzaqla®) treatment of metastatic colorectal cancer and to provide insights into best practices and treatment optimization
  • Fruquintinib Uses, Side Effects Warnings - Drugs. com
    What is fruquintinib? Fruquintinib is used in adults to treat colorectal cancer fruquintinib is used when the cancer has spread to other parts of the body (metastatic) Fruquintinib is given after other treatments did not work or stopped working Fruquintinib may also be used for purposes not listed in this medication guide





中文字典-英文字典  2005-2009